Helius Medical Technologies, Inc. Reports Inducement Grant Under

Helius Medical Technologies

NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT)  announced that, effective September 13, 2022, its compensation committee recently approved an equity award under Helius’ 2021 Inducement Plan, as a material inducement to an individual entering into employment with the Company.

The Company states that the equity award was approved in accordance with Nasdaq Listing Rule 5635(c)(4), which also requires a public announcement of equity awards that are not made under a stockholder-approved equity plan.

In connection with entering into employment with Helius, the individual, who was not a previous employee or director of Helius, received an option to purchase 10,000 shares of the Company’s Class A common stock. The option award has an exercise price of $0.54 per share, the closing price of Helius’ common stock on September 13, 2022, the date of the grant. The option has a ten-year term and vests over a period of four years, with 25% vesting on each of the first, second, third and fourth anniversary of September 1, 2022, provided the new hire’s employment is continuing on each such date, and subject to acceleration or forfeiture upon the occurrence of certain events as set forth in the new hire’s option agreement.

More For You

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News.

Thanks for visiting! Looking for some Chester County pride? We got you covered! Shop our MyChesCo store and show your love for Chester County, Pennsylvania. We got shirts, hats, and more – all with a unique ChesCo flair. Plus, proceeds from each purchase helps support our mission of bringing reliable information and resources to the people of Chester County.